Innovations Composition for treating lung fibrosis & emphysema & therapeutic method using the same
■Technology Introduction
A therapeutic approach for chronic lung diseases such as COPD and fibrosis, via in vivo reprogramming of endogenous alveolar epithelial cells.
■Scientific Innovation
Instead of transplanting in vitro propagated stem cells to injury site, this technology induces vivo reprogramming of endogenous lung cells for therapy.
■This technology won the Futuretech Breakthrough Award in 2019 Future Tech Expo. 

National Yang-Ming University
Erh-Hsuan Lin/